We are pleased to announce that Prof. Enrico Mini joined Innovative Medicines & Omics as Editor-in-Chief. Name: Prof. Enrico Mini Email: enrico.mini@unifi.itAffiliation: Emeritus Professor of Medical Oncology, Department of Health Sciences, University of Florence, Florence, ItalyHomepage: https://www.researchgate.net/profile/Enrico-MiniResearch Interests: Gastrointestinal Cancers; Tumor Drug Resistance; Cancer Pharmacogenomics and Pharmacogenetics; Anticancer Drug Synergism Prof. Mini is an Emeritus Professor of Medical Oncology at the Department of Health Sciences, University of Florence (Italy). His research interests comprise the mechanisms of tumor drug resistance, in particular to antimetabolites and metal-based drugs, cancer pharmacogenomics and pharmacogenetics, and controlled clinical trials in gastrointestinal cancers. His studies have contributed to the advancement of knowledge in the field of biochemical bases of anticancer drug synergism and molecular bases of anticancer drug resistance. Prof. Mini is the author of more than 190 original articles in international peer-reviewed journals and about 80 reviews, editorials, book chapters, and letters. He has given over 260 invited talks at national and international conferences and seminars at Italian and foreign universities and has presented more than 350 communications at scientific congresses. In recognition of his outstanding achievements, Prof. Mini has received various awards and recognitions and grants for his research results, including the Leukemia Society of America Special Fellow Award in 1982, the Lady Tata Memorial Trust Award, the Alberico Benedicenti Italian Society of Pharmacology Special Mention Award in 1988 and in 2019 the 'International Society of Antimicrobial Chemotherapy (ISAC) Fellow Award (London). Prof. Mini has also held prestigious positions in various scientific societies. He is currently the Coordinator of the Cancer Pharmacology Working Group of the Italian Society of Pharmacology. We warmly welcome Prof. Enrico Mini in his new role as Editor-in-Chief, and we look forward to his leading Innovative Medicines & Omics to many more milestones.

Innovative Medicines & Omics [IMO] publishes rigorously peer-reviewed and high-quality original research articles and authoritative reviews that focus on pharmacy and omics in the field of animal and human health.  Now we are currently looking for 1-2 Associate Editors for our journal. This is an opportunity to exchange with and learn from experts in the same field. IMO is an international, double-blind peer-reviewed, quick-refereeing open-access journal. The journal was launched in April, 2023 by cooperating with Beijing University of Chemical Technology by Singapore AccScience Publishing (ASP, https://accscience.com/).  We have already established a very good Editorial Board: https://accscience.com/journal/IMO/about/editorial_board We encourage applications from researchers with a background in a range of subject areas (https://accscience.com/journal/IMO/about/aims_scope).Should you decide to serve on this position, you would be responsible for some of the following tasks depending on your availability: - Assisting the Editor-in-Chief in journal management;- Inviting additional scientists to join the Editorial Board;- Recommending timely topics and suggesting potential guest editors;- Publishing one paper per year, free of charge, in open access;- Promoting the journal. As we provide a low-cost publishing service in open access format, we unfortunately cannot additionally pay an honorarium. The term of the Associate Editor membership is three years and could then be renewed. We believe that your expertise together with our rigorous editorial policies can build a high-standard journal specifically dedicated to Pharmacy and Omics research. If you are interested in becoming an Associate Editor for IMO, please send your full academic CV and a short cover letter that details your interest and enthusiasm for the position to imo.office@accscience.sg <imo.office@accscience.sg>. Welcome to join us! Innovative Medicines & Omics Editorial Office

Innovative Medicines & Omics [IMO] publishes rigorously peer-reviewed and high-quality original research articles and authoritative reviews that focus on pharmacy and omics in the field of animal and human health.  Now we are currently looking for Editorial Board Members for our journal. This is an opportunity to exchange with and learn from experts in the same field. As you may know, IMO is an international, double-blind peer-reviewed, quick-refereeing open-access journal. The journal was launched in April, 2023 by cooperating with Beijing University of Chemical Technology by Singapore AccScience Publishing (ASP, https://accscience.com/). We have already established a very good Editorial Board:https://accscience.com/journal/IMO/about/editorial_board  We encourage applications from researchers with a background in a range of subject areas (https://accscience.com/journal/IMO/about/aims_scope). If you are passionate about participating in cutting-edge research publications, please do not hesitate to contact us about joining the board and contributing to the journal. This position is open to experts in all aspects of medicine and omics research. To apply for this position, recommend potential candidates or request further information, please contact (imo.office@accscience.sg) from the Innovative Medicines & Omics Editorial Office.   Welcome to join us! Innovative Medicines & Omics Editorial Office